Notable Stocks Under Consideration: Hain Celestial Group Inc (NASDAQ:HAIN), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

On Friday, Shares of Hain Celestial Group Inc (NASDAQ:HAIN), subtract -3.62% and closed at $34.38 in the last trading session. The last trading range of the stock ranges between $34.36 and $35.65. The Hain Celestial Group, Inc. (NASDAQ: HAIN), a leading organic and natural products company with operations in North America, Europe and India providing consumers with A Healthier Way of Life™, declared recently that the Listing Qualifications Staff (the “Staff”) of The NASDAQ Stock Market LLC (“Nasdaq”) has granted the Company’s request for an exception to Nasdaq’s filing requirement, as set forth in Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all periodic financial reports with the Securities and Exchange Commission (the “SEC”).

ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), jumped 0.29% and closed at $6.80 in the last trading session. The last trading range of the stock ranges between $6.42 and $6.99. The company’s Market capitalization is $898.42 million with the total Outstanding Shares of 131.73 million. ZIOPHARM Oncology, Inc. (ZIOP) recently declared that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies 2016 London Healthcare Conference on Thursday, November 17, 2016 at 4:40 p.m. GMT.

As formerly declared, ZIOPHARM will host a conference call and webcast slide presentation Thursday, November 17, 2016, at 8:00 am ET to discuss information featured at the Society for Neuro-Oncology (SNO) Annual Meeting, counting updated data from the Company’s Phase 1 study of Ad-RTS-hIL-12 + veledimex in high-grade glioma. The call can be accessed by dialing (844) 309-0618 (U.S. and Canada) or (661) 378-9465 (international).

Leave a Reply

Your email address will not be published. Required fields are marked *